Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality
EP Europace · 2023
DOI: 10.1093/europace/euac170 ↗Kurz gefasst
Fachartikel in der Zeitschrift EP Europace, 2023. Verfasst von Marc W Deyell und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, University of British Columbia, #200-1033 Davie Street, Vancouver, BC, Canada V6E 1M7. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cryosurgery, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Division of Cardiology Academic Practice Plan.
Abstract (Originalsprache)
Aims
Same-day discharge is increasingly common after catheter ablation for atrial fibrillation (AF). However, the impact of same-day discharge on healthcare utilization after ablation and whether this differs by ablation modality remains uncertain. We examined the safety, efficacy, and subsequent healthcare utilization of a same-day discharge protocol for AF ablation, including radiofrequency (RF) and cryoballoon ablation, in a contemporary cohort. Methods and results All consecutive patients for whom full healthcare utilization data were available at two centres and who underwent AF ablation from 2018 to 2019 were included. Same-day discharge was the default strategy for all patients. The efficacy and safety outcomes were proportions of same-day discharge and readmission/emergency room (ER) visits, and post-discharge complications, respectively. Of the 421 patients who underwent AF ablation (mean 63.3 ± 10.2 years, 33% female), 90.5% (381/421) achieved same-day discharge with no difference between RF and cryoballoon ablation (89.8 vs. 95.1%, adjusted P = 0.327). Readmission ≤30 days occurred in 4.8%, with ER visits ≤30 days seen in 26.1% with no difference between ablation modalities (P = 0.634). Patients admitted overnight were more likely to present to the ER (40.0 vs. 24.7% with same-day discharge, P = 0.036). The overall post-discharge complication rate was low at 4/421 (1.0%), with no difference between ablation modality (P = 0.324) and admission/same-day discharge (P = 0.485).
Conclusion
Same-day discharge can be achieved in a majority of patients undergoing RF or cryoballoon ablation for AF. Healthcare utilization, particularly ER visits, remains high after AF ablation, regardless of ablation modality or same-day discharge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, University of British Columbia, #200-1033 Davie Street, Vancouver, BC, Canada V6E 1M7.
- Centre for Cardiovascular Innovation, University of British Columbia, 2775 Laurel Street, 9th Floor, Vancouver, BC, Canada V5Z 1M9.
- St. Paul's Hospital, Providence Health Care, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6.
ORCID-Profile: Marc W Deyell, Kurt Hoskin, Jacqueline Forman, Zachary W Laksman, Nathaniel M Hawkins, John A Yeung-Lai-Wah, Andrew D Krahn, Jason G Andrade
Förderung
- Division of Cardiology Academic Practice Plan
Zitieren
APA
Deyell, M. W., Hoskin, K., Forman, J., Laksman, Z. W., Hawkins, N. M., Bennett, M. T., Yeung-Lai-Wah, J. A., Chakrabarti, S., Krahn, A. D., & Andrade, J. G. (2023). Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality. EP Europace. https://doi.org/10.1093/europace/euac170
Vancouver
Deyell MW, Hoskin K, Forman J, Laksman ZW, Hawkins NM, Bennett MT, et al. Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality. EP Europace. 2023. doi:10.1093/europace/euac170
BibTeX
@article{Deyell2023,
author = {Deyell, Marc W and Hoskin, Kurt and Forman, Jacqueline and Laksman, Zachary W and Hawkins, Nathaniel M and Bennett, Matthew T and Yeung-Lai-Wah, John A and Chakrabarti, Santabhanu and Krahn, Andrew D and Andrade, Jason G},
title = {Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality},
journal = {EP Europace},
year = {2023},
doi = {10.1093/europace/euac170}
}
EUVIMED